These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17442430)

  • 1. Sudden death in a patient with lamin A/C gene mutation and near normal left ventricular systolic function.
    Fernández X; Dumont CA; Monserrat L; Hermida-Prieto M; Castro-Beiras A
    Int J Cardiol; 2008 May; 126(1):136-7. PubMed ID: 17442430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
    Kärkkäinen S; Heliö T; Miettinen R; Tuomainen P; Peltola P; Rummukainen J; Ylitalo K; Kaartinen M; Kuusisto J; Toivonen L; Nieminen MS; Laakso M; Peuhkurinen K
    Eur Heart J; 2004 May; 25(10):885-93. PubMed ID: 15140538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotype of sudden cardiac death-An unusual presentation of a family with a Lamin A/C mutation.
    De Backer J; Van Beeumen K; Loeys B; Duytschaever M
    Int J Cardiol; 2010 Jan; 138(1):97-9. PubMed ID: 18691775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrest and left ventricular fibrosis in a Finnish family with the lamin A/C mutation.
    Hookana E; Junttila MJ; Särkioja T; Sormunen R; Niemelä M; Raatikainen MJ; Uusimaa P; Lizotte E; Peuhkurinen K; Brugada R; Huikuri HV
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):743-7. PubMed ID: 18031519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
    Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
    BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene.
    Otomo J; Kure S; Shiba T; Karibe A; Shinozaki T; Yagi T; Naganuma H; Tezuka F; Miura M; Ito M; Watanabe J; Matsubara Y; Shirato K
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):137-45. PubMed ID: 15720451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome and risk stratification in dilated cardiolaminopathies.
    Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
    J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.
    van Rijsingen IA; Arbustini E; Elliott PM; Mogensen J; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Pilotto A; Pasotti M; Jenkins S; Rowland C; Aslam U; Wilde AA; Perrot A; Pankuweit S; Zwinderman AH; Charron P; Pinto YM
    J Am Coll Cardiol; 2012 Jan; 59(5):493-500. PubMed ID: 22281253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamin A/C deficiency as a cause of familial dilated cardiomyopathy.
    Malhotra R; Mason PK
    Curr Opin Cardiol; 2009 May; 24(3):203-8. PubMed ID: 19384091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of sudden death in patients with lamin A/C gene mutations.
    Meune C; Van Berlo JH; Anselme F; Bonne G; Pinto YM; Duboc D
    N Engl J Med; 2006 Jan; 354(2):209-10. PubMed ID: 16407522
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complex double deletion in LMNA underlies progressive cardiac conduction disease, atrial arrhythmias, and sudden death.
    Marsman RF; Bardai A; Postma AV; Res JC; Koopmann TT; Beekman L; van der Wal AC; Pinto YM; Lekanne Deprez RH; Wilde AA; Jordaens LJ; Bezzina CR
    Circ Cardiovasc Genet; 2011 Jun; 4(3):280-7. PubMed ID: 21406687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamin A/C and cardiac diseases.
    Sylvius N; Tesson F
    Curr Opin Cardiol; 2006 May; 21(3):159-65. PubMed ID: 16601451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart involvement in lamin A/C related diseases.
    Ben Yaou R; Gueneau L; Demay L; Stora S; Chikhaoui K; Richard P; Bonne G
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):848-55. PubMed ID: 17067107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel c.367_369del LMNA mutation manifesting as severe arrhythmias, dilated cardiomyopathy, and myopathy.
    Keller H; Finsterer J; Steger C; Wexberg P; Gatterer E; Khazen C; Stix G; Gerull B; Höftberger R; Weidinger F
    Heart Lung; 2012; 41(4):382-6. PubMed ID: 22019351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
    van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
    Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.